Drug Trial Radar · NCT03914326
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Dec 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
9,651
Actual
Start
Jun 17, 2019
Primary completion
Aug 23, 2024
Study completion Aug 23, 2024
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Apr 16, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Participants will either get semaglutide tablets or placebo tablets ("dummy" medicine) - which treatment is decided by chance. Participants must take one tablet with water every morning on an empty stomach and not eat or drink anything for at least 30 minutes. The study will last for about 3.5-5 years. Participants will have up to 25 clinic visits and 1 phone call with the study doctor. Women cannot be in the study if pregnant, breast-feeding or if they plan to become pregnant during the study period.
Conditions
- Diabetes Mellitus, Type 2
Interventions
SemaglutideDrug
Increasing doses (3 mg/7 mg/14 mg) of semaglutide tablets to be taken with water at the same time every morning in a fasting state
Placebo (semaglutide)Drug
Placebo tablets to be taken with water at the same time every morning in a fasting state
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants From Randomization to First Occurrence of a Major Adverse Cardiovascular Event (MACE), a Composite Endpoint Consisting of: Cardiovascular (CV) Death/Non-fatal Myocardial Infarction/Non-fatal StrokeTime frame: From randomisation (week 0) up to week 265
Locations
492 sites in 34 countries. Site status is shown where the registry gives one.
Chambliss Clinical Trials, LLC
Montgomery, Alabama
Medical Investigations, Inc.
Little Rock, Arkansas
Unity Health-Searcy Medical Center
Searcy, Arkansas
B&K Medical Research Center
Fresno, California
University of Vermont Medical Center
Fullerton, California
Scripps Whittier Diabetes Inst
La Jolla, California
Diabetes & Endocrine Associates
La Mesa, California
First Valley Medical Group
Lancaster, California
Pacific Clinical Studies
Los Alamitos, California
Facey Medical Foundation
Mission Hills, California
Monterey Endocrine & Diabetes Institute, Inc
Monterey, California
Desert Oasis Hlthcr Med Group
Palm Springs, California
San Diego Family Care
San Diego, California
Lundquist Inst-Biomed Innovtn
Torrance, California
Coastal Metabolic Research Center
Ventura, California
Rocky Mount Reg VA Med-DN
Aurora, Colorado
Creekside Endocrine Associates, PC
Denver, Colorado
New West Physicians,Inc.
Golden, Colorado
East Coast Medical Associates, Inc.
Boca Raton, Florida
Suncoast Clin Res Port Richey
New Port Richey, Florida
AdventHealth Diab Inst
Orlando, Florida
Ellipsis Group
Alpharetta, Georgia
Physicians Research Assoc. LLC
Lawrenceville, Georgia
Endo Res Solutions Inc
Roswell, Georgia
East West Med Res Inst
Honolulu, Hawaii
Rocky Mountain Diab&Osteo Ctr
Idaho Falls, Idaho
Clinical Invest Special_Gurnee
Gurnee, Illinois
American Health Network of IN LLC_Franklin
Franklin, Indiana
American Health Network of Indiana, LLC_Greenfield
Greenfield, Indiana
Franciscan Health Michigan City
Michigan City, Indiana
American Health Network of IN LLC
Muncie, Indiana
Iowa Diab & Endo Res Center
West Des Moines, Iowa
The Research Group of Lexington LLC
Lexington, Kentucky
Robley Rex VA Medical Center
Louisville, Kentucky
L-MARC Research Center
Louisville, Kentucky
Tulane University Health Sciences Center
New Orleans, Louisiana
Ileana J Tandron APMC
Slidell, Louisiana
Northern Pines Hlth Ctr, PC
Buckley, Michigan
Methodist Phys. Clinic
Omaha, Nebraska
Univ of Nebraska Medical CTR
Omaha, Nebraska
Showing 40 of 492 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.